FDA's generic drug enforcement and approval process
Subtitle: hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1992
Place of publication: Washington
Language: eng
Number of pages: 587
Subjects: United States. Food and Drug Administration.; Pharmaceutical industry -- Corrupt practices -- United States.; Pharmaceutical industry -- United States -- Quality control.; Generic drugs -- United States.
Notes: Includes bibliographical references.
Item 1019-A, 1019-B (MF)
Distributed to some depository libraries in microfiche.
Shipping list no.: 92-185-P.
"Serial no. 102-77."